Cargando…
Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease
Decision-making is considered a fundamental aspect of personal autonomy and can be affected in psychiatric and neurologic diseases. It has been shown that cognitive deficits in dementia impact negatively on decision-making. Moreover, studies highlighted impaired clinical competence in neuropsychiatr...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472652/ https://www.ncbi.nlm.nih.gov/pubmed/28670272 http://dx.doi.org/10.3389/fnagi.2017.00182 |
_version_ | 1783244152323964928 |
---|---|
author | Bertrand, Elodie van Duinkerken, Eelco Landeira-Fernandez, J. Dourado, Marcia C. N. Santos, Raquel L. Laks, Jerson Mograbi, Daniel C. |
author_facet | Bertrand, Elodie van Duinkerken, Eelco Landeira-Fernandez, J. Dourado, Marcia C. N. Santos, Raquel L. Laks, Jerson Mograbi, Daniel C. |
author_sort | Bertrand, Elodie |
collection | PubMed |
description | Decision-making is considered a fundamental aspect of personal autonomy and can be affected in psychiatric and neurologic diseases. It has been shown that cognitive deficits in dementia impact negatively on decision-making. Moreover, studies highlighted impaired clinical competence in neuropsychiatric disorders, such as schizophrenia and bipolar disorder. In this context, the current study explored the relationship between behavioral and psychological symptoms of dementia (BPSD) and clinical competence, especially the capacity to consent to treatment, in Alzheimer’s disease (AD). Seventy-one patients with mild to moderate AD participated, completing assessments for capacity to consent to treatment, general cognition and neuropsychiatric disturbances. For each neuropsychiatric symptom, patients with and without the particular disturbance were compared on the different subscales of the MacArthur Competence Tool for Treatment (MacCAT-T; Understanding, Appreciation, Reasoning and Expression). The results showed that patients presenting delusions, as well as apathetic patients, had a lower ability to express a clear treatment choice compared to patients without these symptoms. By contrast, patients with dysphoria/depression had higher scores on this variable. Additionally, AD patients with euphoria had more difficulties discussing consequences of treatment alternatives compared to patients without this disturbance. None of the differences were confounded by global cognition. There were no between-group differences in clinical decision-making for patients with hallucinations, agitation/aggression, anxiety, irritability, disinhibition and aberrant motor behavior. These findings highlight the importance of taking BPSD into account when assessing decision-making capacity, especially clinical competence, in AD. Furthermore, reducing BPSD may lead to better clinical competence in patients with AD, as well as to improvements in patients and caregivers’ quality of life. |
format | Online Article Text |
id | pubmed-5472652 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54726522017-06-30 Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease Bertrand, Elodie van Duinkerken, Eelco Landeira-Fernandez, J. Dourado, Marcia C. N. Santos, Raquel L. Laks, Jerson Mograbi, Daniel C. Front Aging Neurosci Neuroscience Decision-making is considered a fundamental aspect of personal autonomy and can be affected in psychiatric and neurologic diseases. It has been shown that cognitive deficits in dementia impact negatively on decision-making. Moreover, studies highlighted impaired clinical competence in neuropsychiatric disorders, such as schizophrenia and bipolar disorder. In this context, the current study explored the relationship between behavioral and psychological symptoms of dementia (BPSD) and clinical competence, especially the capacity to consent to treatment, in Alzheimer’s disease (AD). Seventy-one patients with mild to moderate AD participated, completing assessments for capacity to consent to treatment, general cognition and neuropsychiatric disturbances. For each neuropsychiatric symptom, patients with and without the particular disturbance were compared on the different subscales of the MacArthur Competence Tool for Treatment (MacCAT-T; Understanding, Appreciation, Reasoning and Expression). The results showed that patients presenting delusions, as well as apathetic patients, had a lower ability to express a clear treatment choice compared to patients without these symptoms. By contrast, patients with dysphoria/depression had higher scores on this variable. Additionally, AD patients with euphoria had more difficulties discussing consequences of treatment alternatives compared to patients without this disturbance. None of the differences were confounded by global cognition. There were no between-group differences in clinical decision-making for patients with hallucinations, agitation/aggression, anxiety, irritability, disinhibition and aberrant motor behavior. These findings highlight the importance of taking BPSD into account when assessing decision-making capacity, especially clinical competence, in AD. Furthermore, reducing BPSD may lead to better clinical competence in patients with AD, as well as to improvements in patients and caregivers’ quality of life. Frontiers Media S.A. 2017-06-16 /pmc/articles/PMC5472652/ /pubmed/28670272 http://dx.doi.org/10.3389/fnagi.2017.00182 Text en Copyright © 2017 Bertrand, van Duinkerken, Landeira-Fernandez, Dourado, Santos, Laks and Mograbi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Bertrand, Elodie van Duinkerken, Eelco Landeira-Fernandez, J. Dourado, Marcia C. N. Santos, Raquel L. Laks, Jerson Mograbi, Daniel C. Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease |
title | Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease |
title_full | Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease |
title_fullStr | Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease |
title_full_unstemmed | Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease |
title_short | Behavioral and Psychological Symptoms Impact Clinical Competence in Alzheimer’s Disease |
title_sort | behavioral and psychological symptoms impact clinical competence in alzheimer’s disease |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472652/ https://www.ncbi.nlm.nih.gov/pubmed/28670272 http://dx.doi.org/10.3389/fnagi.2017.00182 |
work_keys_str_mv | AT bertrandelodie behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease AT vanduinkerkeneelco behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease AT landeirafernandezj behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease AT douradomarciacn behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease AT santosraquell behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease AT laksjerson behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease AT mograbidanielc behavioralandpsychologicalsymptomsimpactclinicalcompetenceinalzheimersdisease |